Passos
Passos
Passos, Minas Gerais, Brazil7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack | Acute Myocardial Infarction (AMI); Cardiovascular Risk | Active, not recruiting | Phase 3 | 2026-09-09 | NCT06118281 | |
| Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, tracheobronchitis | Active, not recruiting | Not applicable | 2026-07-27 | NCT05266066 | |
| Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease | Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Skin and Connective Tissue Diseases, Unilateral Breast Neoplasms, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-05-19 | NCT06760637 | |
| Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units | Catheter-Related Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Healthcare-Associated Pneumonia, Infections, Infections, Hospital, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumonia, Ventilator-Associated, Urogenital Diseases, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder, urinary system disorder, urinary tract infection | Recruiting | Not applicable | 2026-04-15 | NCT07233837 | |
| Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Active, not recruiting | Phase 3 | 2025-12-17 | NCT06211036 | |
| Quality Improvement Intervention for a Safe Antimicrobial Use Reduction in Critically Ill Patients | Infections | Recruiting | Not applicable | 2025-12-03 | NCT07093450 | |
| Oral Care Layered Enhancement for Improved Oral Hygiene in Intensive Care Units | Critical Illness, Disease Attributes, Healthcare-Associated Pneumonia, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumonia, Ventilator-Associated, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not applicable | 2025-08-19 | NCT07129733 |